ASSESSMENT OF PHARMACEUTICAL MANUFACTURERS’ COMPETITIVENESS
Milena Filipova
Yulia Nedelcheva
Abstract
The aim of the article is to assess the competitiveness of pharmaceutical manufacturers. The assessment was carried out for six producers in Bulgaria with largest volume of production. The assessment is based on a model, which is a combination of quantitative and qualitative indicators of manufacturers. The answers of 52 respondents from a survey were used to determine the quality indicators of the model. The results of assessment identify quality indicators as leading to manufacturer competitiveness. The competitiveness of the product (ratio of product quality to price) has the greatest weight in assessment the manufacturer competitiveness. The quantitative indicators of the individual producers have similar values and therefore have little effect on the assessment of their competitiveness. The state participates in the assessment of the competitiveness of pharmaceutical manufacturers by determining of pharmaceutical products that price is paid partially by a competent authority.
Keywords: Bulgaria; survey; pharmaceutical products
JEL Codes: D22; I11; L11
REFERENCES
Dimitrova, R. (2014). Monitoring na konkurentosposobnostta na predpriyatieto. Blagoevgrad: Universitetsko izdatelstvo „N. Rilski“.
Ilieva-Tonova, D., Stoimenova, A. & Pencheva, I. (2016). Market Surveillance and Control of Medicinal Products in Bulgaria 2009 – 2015. Science & Technologies, VI (1), 365-373.
Ilieva-Tonova, D., Pencheva, I. & Serbezova, A. (2022). HPLC Tests in Quality Control under the Market Surveillance Program for Medicinal Products Containing Amlodipine and Valsartan. Current Pharmaceutical Analysis, 18.
Keremidchiev, Sp. & Nedelchev, M. (2022). Corporate Governance Assessment of State-Owned Hospitals. Bulgarian Journal of Public Health, 14(1), 3-14.
Madgerova, R. & Kyurova, V. (2014). Definition, characteristics and problems of family business. Economics and Management, X (2), 97-105.
Nedelchev, M. (2019). Corporate Governance of State-Owned Enterprises: the Case of Healthcare Establishments in Bulgaria. Economic Studies, 1, 115-123.
Nedeltchev, Dr. (2005). Social capital and economic development. Sofia: Akademichno izdatelstvo Marin Drinov.
Petrova, G. (2018). Some New Pharmacologic Options for Open-Angle Glaucoma. World Journal of Pharmacy and Pharmaceutical sciences, 6, 29.
Velev, M. (2004). Otsenka i analiz na konkurentosposobnostta na firmata. Sofiya: Softtrejd.
Yuleva, R. (2019). Competitive Advantages and Competitive Strategies of Small and Medium-Sized Enterprises. Economics and Management, XVІ (1), 71-81.
Full text: PDF (English)
To cite this article: FILIPOVA M., Y. NEDELCHEVA (2022). Assessment of pharmaceutical manufacturers’ competitiveness. Entrepreneurship, 10 (1), 60-67 DOI: 10.37708/ep.swu.v10i1.6
